Novo Integrated Sciences, Inc. reported earnings results for the second quarter and six months ended February 29, 2024. For the second quarter, the company reported sales was USD 3.17 million compared to USD 2.56 million a year ago. Net loss was USD 2.75 million compared to USD 4.62 million a year ago. Basic loss per share from continuing operations was USD 0.16.
For the six months, sales was USD 7.06 million compared to USD 5.98 million a year ago. Net loss was USD 7.43 million compared to USD 8.56 million a year ago. Basic loss per share from continuing operations was USD 0.43 compared to USD 1.52 a year ago.